These elevated systemic sCD14 levels detected in patients with anxiety were consistent with high systemic CD163 levels (another marker of monocyte activation) found in the bloodstream of COVID-19-infected patients, which could enhance monocyte–macrophage mobilization [53]. Here, CD163 is linked to COVID-19.